Dipartimento di Scienze della Vita e della Riproduzione, Sezione di Chimica Biologica, Facoltà di Medicina e Chirurgia, Università degli Studi di Verona, Strada Le Grazie, 8 37134 Verona, Italy.
Biochimie. 2010 Dec;92(12):1801-11. doi: 10.1016/j.biochi.2010.08.005. Epub 2010 Aug 14.
The sensitivity to denaturant stress of the major (AGT-Ma) and the minor (AGT-Mi) allele of alanine:glyoxylate aminotransferase and P11L mutant has been examined by studying their urea-induced equilibrium unfolding processes with various spectroscopic and analytical techniques. AGT-Ma loses pyridoxal 5'-phosphate (PLP) and unfolds completely without exposing significant hydrophobic clusters through a two-state model (C(m) ∼ 6.9 M urea). Instead, the unfolding of AGT-Mi and P11L variant proceeds in two steps. The first transition (C(m) ∼ 4.6 M urea) involves PLP release, dimer dissociation and exposure of hydrophobic patches leading to a self-associated intermediate which is converted to an unfolded monomer in the second step. The unfolding pathways of apoAGT-Mi and apoP11L are similar to each other, but different from that of apoAGT-Ma. Notably, the monomerization step in apoAGT-Mi and apoP11L occurs with a C(m) value (∼1.6 M urea) lower than in apoAGT-Ma (∼2.4 M urea). These data indicate that Pro11 is relevant for the stability of both the dimeric structure and the PLP binding site of AGT. Moreover, to understand the pathogenic consequences of G170R mutation on AGT-Mi at the protein level, G170R-Mi has been characterized. HoloG170R-Mi exhibits spectroscopic and catalytic features and urea unfolding profiles comparable to those of AGT-Mi, while the apo form monomerizes with a C(m) of ∼1.1 M urea. These biochemical results are discussed in the light of the characteristics of the enzymatic phenotype of PH1 patients bearing G170R mutation in AGT-Mi and the positive response of these patients to pyridoxine treatment.
乙醛酸氨基转移酶(AGT)的主要(AGT-Ma)和次要(AGT-Mi)等位基因及其 P11L 突变体在变性剂压力下的敏感性,利用各种光谱和分析技术研究了它们的尿素诱导平衡展开过程。AGT-Ma 失去吡哆醛 5'-磷酸(PLP)并通过两态模型(C(m)∼6.9 M 尿素)完全展开而不暴露明显的疏水区簇。相反,AGT-Mi 和 P11L 变体的展开分两步进行。第一个转变(C(m)∼4.6 M 尿素)涉及 PLP 释放、二聚体解离和暴露疏水区导致自缔合中间物,该中间物在第二步转化为无规卷曲单体。apoAGT-Mi 和 apoP11L 的展开途径彼此相似,但与 apoAGT-Ma 不同。值得注意的是,apoAGT-Mi 和 apoP11L 中的单体化步骤的 C(m)值(∼1.6 M 尿素)低于 apoAGT-Ma(∼2.4 M 尿素)。这些数据表明 Pro11 与 AGT 的二聚体结构和 PLP 结合位点的稳定性都有关。此外,为了在蛋白质水平上理解 G170R 突变对 AGT-Mi 的致病后果,对 G170R-Mi 进行了表征。HoloG170R-Mi 表现出与 AGT-Mi 相当的光谱和催化特征以及尿素展开曲线,而apo 形式则以 C(m)为∼1.1 M 尿素单体化。这些生化结果在考虑到携带 G170R 突变的 PH1 患者的 AGT-Mi 酶表型特征和这些患者对吡哆醇治疗的阳性反应的情况下进行了讨论。